Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Mars, Incorporated to acquire VCA Inc.
hand shake
The transaction is expected to complete later in 2017.
Transaction price set at around $9.1 billion

Mars, Incorporated has entered an agreement to acquire VCA Inc., which owns nearly 800 animal hospitals in the US and Canada.

Mars is set to acquire all outstanding shares of VCA for $93 per share - a total value of around $9.1 billion, which includes $1.4 billion in outstanding debt.

When the acquisition is complete VCA will operate as a distinct business unit within Mars Petcare, alongside other veterinary businesses; Banfield Pet Hospital, Bluepearl and Pet Partners. VCA will continue to be led by Bob Antin, its chief executive officer, president, chairman and founder.

Since it was founded in 1986, VCA has grown to nearly 800 veterinary hospitals with 60 diagnostic laboratories. The company operates across four divisions: veterinary services, laboratory diagnostics, imaging equipment and medical technology and pet care services.

Mars CEO Grant F Reid commented: “We are thrilled to welcome VCA to the Mars family and to our portfolio of brands and businesses around the world.

“VCA is a leader across pet health care and the opportunity we see together - for pets, pet owners, veterinarians and other pet care providers - is tremendous.

“We have great respect for VCA, with whom we share many common values and a strong commitment to pet care. Together, we will be able to provide even greater value, better service and higher quality care to pets and pet owners.”

The transaction is subject to VCA shareholder approval, customary regulatory approval, and other conditions. It is expected to complete later in 2017.

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk